GEP20012524B - Assessment of Injuries of Nephritic Tissue - Google Patents

Assessment of Injuries of Nephritic Tissue

Info

Publication number
GEP20012524B
GEP20012524B GEAP20005365A GEAP2000005365A GEP20012524B GE P20012524 B GEP20012524 B GE P20012524B GE AP20005365 A GEAP20005365 A GE AP20005365A GE AP2000005365 A GEAP2000005365 A GE AP2000005365A GE P20012524 B GEP20012524 B GE P20012524B
Authority
GE
Georgia
Prior art keywords
nephritic
injuries
tissue
assessment
diagnosis
Prior art date
Application number
GEAP20005365A
Inventor
Tinatin Metreveli
Nino Kakhishvili
Original Assignee
Tinatin Metreveli
Nino Kakhishvili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tinatin Metreveli, Nino Kakhishvili filed Critical Tinatin Metreveli
Priority to GEAP20005365A priority Critical patent/GEP20012524B/en
Publication of GEP20012524B publication Critical patent/GEP20012524B/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

1. Technical Result Simplification of the method and increase in accuracy of diagnosis. 2. Essence The activity of arginase enzyme is defined in urine and degree of injuries of nephritic tissue is assessed. 3. Field of Application Medicine, diagnosis.
GEAP20005365A 2000-05-23 2000-05-23 Assessment of Injuries of Nephritic Tissue GEP20012524B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP20005365A GEP20012524B (en) 2000-05-23 2000-05-23 Assessment of Injuries of Nephritic Tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP20005365A GEP20012524B (en) 2000-05-23 2000-05-23 Assessment of Injuries of Nephritic Tissue

Publications (1)

Publication Number Publication Date
GEP20012524B true GEP20012524B (en) 2001-08-27

Family

ID=82608774

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP20005365A GEP20012524B (en) 2000-05-23 2000-05-23 Assessment of Injuries of Nephritic Tissue

Country Status (1)

Country Link
GE (1) GEP20012524B (en)

Similar Documents

Publication Publication Date Title
BR9710984A (en) Use of a polymer, homopolymer or copolymer in obtaining a medication to treat a gastrointestinal or microbial infection in a mammal
BR9910251A (en) Hematopoietic stimulation
TR200000694T2 (en) A method to maintain or improve skin health.
FR2810539B1 (en) PROCESS AND DEVICE FOR TREATING, PARTICULARLY MAKEUP, COLORING OR COSMETIC CARE, OF PARTS OR THE WHOLE OF THE HUMAN OR ANIMAL BODY
IL149896A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
IL133265A0 (en) Heparanase specific molecular probes and their use in research and medical applications
DE69615561T2 (en) POLYETHER BLOCK COPOLYMERS MICELLARE COMPOSITIONS FOR THE TARGETED ADMINISTRATION OF BIOLOGICAL SUBSTANCES
DE69421778T2 (en) Use of effective amounts of active substances for the treatment of combination skin
DE69636507D1 (en) Blood container, and instrument and device for the delivery of blood
TR200101769T2 (en) Devices and processes that facilitate the application of biological substances.
SE9702860D0 (en) New use
WO1999015643A3 (en) ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE
WO1997011667A3 (en) Therapeutic applications using horse serum
DE69625918D1 (en) LONG-EFFECTIVE AGENT FOR RECTAL ADMINISTRATION
TW363887B (en) Surgical implement
WO2002009735A3 (en) Methods and devices to modulate the wound response
FR2782922B1 (en) COMPOSITION CONTAINING UREA AND ITS USES IN THE COSMETIC AND / OR DERMATOLOGICAL FIELD
DK0791073T3 (en) Analysis Method
TR200501763T2 (en) Treatment and screening methods
GEP20012524B (en) Assessment of Injuries of Nephritic Tissue
FR2802213B1 (en) BACTERIA "RICKETTSIA PULICIS" METHOD OF ISOLATION IN CULTURE AND SEROLOGICAL DIAGNOSIS
EP2202241A3 (en) Therapeutic compounds and methods for modulating V3, a versican isoform
WO2001089558A3 (en) Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
DE60033416D1 (en) USE OF HYPOESTOXIDES AS ANTIPARASITIC AGENTS
WO2002085325A3 (en) Production and use of a suspension composition comprising an ultrasound contrast medium